Nucleix Ltd.
Clinical trials sponsored by Nucleix Ltd., explained in plain language.
-
Simple urine test could replace painful scope for bladder cancer detection
Diagnosis Recruiting nowThis study is testing a new urine test called Bladder EpiCheck to see if it can accurately detect bladder cancer in people aged 45 and older who have blood in their urine. The test results will be compared to the standard procedure, cystoscopy, which uses a camera to look inside …
Sponsor: Nucleix Ltd. • Aim: Diagnosis
Last updated Apr 26, 2026 19:36 UTC
-
Your urine could help create a better bladder cancer test
Knowledge-focused Recruiting nowThis study collects urine samples from 1,000 people who may have bladder cancer or are being monitored for it. The goal is to help develop a new test called Bladder EpiCheck. Participants provide one urine sample and share basic health information. No treatment or follow-up is in…
Sponsor: Nucleix Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 03:08 UTC